Literature DB >> 11968013

Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors.

S A Khan1, C A Lopez-Chua, J Zhang, L W Fisher, E S Sørensen, D T Denhardt.   

Abstract

Osteopontin (OPN) is primarily an extracellular glycosylated phosphoprotein capable of stimulating cell migration and cell attachment, predominantly to mineralized surfaces. Found in moderate levels in plasma, it acts as a cytokine able to modify gene expression via integrins and certain CD44 isoforms. In this work we show that soluble OPN inhibits apoptosis of adherent human umbilical vein endothelial cells incubated in medium lacking critical growth factors and cytokines. In a dose-dependent manner OPN reduced the formation of apoptotic bodies and suppressed DNA fragmentation. OPN also caused an increase in Bcl-X(L) mRNA levels, suppressed the apparent dispersion of Bcl-X(L) throughout the cytoplasm, and slightly enhanced IkappaB-alpha protein degradation. These data suggest that a function of OPN in homeostatic processes is to facilitate the survival of stressed endothelial cells, possibly by occupying unligated integrins and suppressing integrin-mediated death. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968013     DOI: 10.1002/jcb.10170

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  27 in total

1.  Upregulation of osteopontin by osteocytes deprived of mechanical loading or oxygen.

Authors:  Ted S Gross; Katy A King; Natalia A Rabaia; Pranali Pathare; Sundar Srinivasan
Journal:  J Bone Miner Res       Date:  2004-10-11       Impact factor: 6.741

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

Authors:  Dinender K Singla; Reetu D Singla; Debbie E McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

4.  Angiopoietins in haematopoietic stem cell mobilisation in patients with haematological malignancies.

Authors:  Anna Szmigielska-Kaplon; Anna Krawczynska; Magdalena Czemerska; Agnieszka Pluta; Barbara Cebula-Obrzut; Katarzyna Szmigielska; Konrad Stępka; Piotr Smolewski; Tadeusz Robak; Agnieszka Wierzbowska
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

5.  Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435.

Authors:  Lalita A Shevde; Rajeev S Samant; Jason C Paik; Brandon J Metge; Ann F Chambers; Graham Casey; Andra R Frost; Danny R Welch
Journal:  Clin Exp Metastasis       Date:  2006-07-09       Impact factor: 5.150

6.  Differential expression of intracellular and secreted osteopontin isoforms by murine macrophages in response to toll-like receptor agonists.

Authors:  Wei Zhao; Lijuan Wang; Lei Zhang; Chao Yuan; Paul C Kuo; Chengjiang Gao
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

Review 7.  Osteopontin: an effector and an effect of tumor metastasis.

Authors:  L A Shevde; S Das; D W Clark; R S Samant
Journal:  Curr Mol Med       Date:  2010-02       Impact factor: 2.222

8.  The cytokine osteopontin modulates the severity of rotavirus diarrhea.

Authors:  Ellen E Rollo; Scott J Hempson; Ajay Bansal; Ernest Tsao; Iman Habib; Susan R Rittling; David T Denhardt; Erich R Mackow; Robert D Shaw
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

Review 9.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

10.  The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Authors:  Donald Courter; Hongbin Cao; Shirley Kwok; Christina Kong; Alice Banh; Peiwen Kuo; Donna M Bouley; Carmen Vice; Odd Terje Brustugun; Nicholas C Denko; Albert C Koong; Amato Giaccia; Quynh-Thu Le
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.